Stronger fuel standards and cleaner technologies are driving major efficiency gains in China’s heavy-duty vehicle fleet, ...

Hepatitis delta virus (HDV), a bloodborne infection that is transmitted through infected blood or other bodily fluids, was ...

Ohio sheriff takes defiant stance on immigration, draws spotlight Drone footage shows river breaking its banks in Washington ...

Lilly is investigating the triple G agonist retatrutide in seven other Phase III trials, which are due to read out in 2026.

Learn everything you need to know about iShares Core High Dividend ETF (HDV) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it's the ...

The complete 96-week and post-treatment follow up data from the Phase 1 monotherapy (NCT04536337) cohorts in subjects with chronic HBV infection show the continued potential of pevifoscorvir sodium to ...

Mirum Pharmaceuticals Inc. (NASDAQ:MIRM) is one of the best biotech stocks to buy according to Wall Street analysts. On ...

While today’s stocks might mean you have to take on more risk to replicate Buffett’s hypothetical 3% return, understanding ...

Lyon's 'Fete des Lumieres', or Festival of Lights, which features intricate light displays projected on historical monuments ...

Titles marked with an asterisk required upscaling to hit that performance level.

As of Tuesday, December 02, Vir Biotechnology, Inc.’s VIR share price has dipped by 8.57%, which has investors questioning if this is right time to buy.

(Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced positive interim results from two Phase 1b studies of its investigational ...